Merck

Update in progress

MRK (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Merck & Co., Inc. is a global healthcare company based in Rahway, New Jersey. It develops and markets human health medicines and vaccines, including Keytruda, Gardasil, Pneumovax, Januvia/Janumet, Bravecto, and additional therapies. The company also offers veterinary vaccines, livestock and companion-animal health products, and health-management services. It collaborates with Daiichi Sankyo, AstraZeneca, LaNova, Eisai, Bayer, Ridgeback, Infinimmune, and Moderna.

Company score

Sentiment: 1.29; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.39; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.83; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.31; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.31; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.80; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive